04/24/2024 3:30 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 3:20 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 3:48 PM | CureVac (Subject) Greune Malte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024 4:10 PM | CureVac (Subject) GSK plc (Filed by)
| Form SC 13G/A | |
|
01/17/2024 8:02 AM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 2:19 PM | CureVac (Subject) Mendila Myriam (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 1:57 PM | CureVac (Subject) Greune Malte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 2:09 PM | CureVac (Subject) Zehnder Alexander (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 1:41 PM | CureVac (Subject) Kemula Pierre (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 3:30 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2023 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023 3:45 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/12/2023 3:15 PM | CureVac (Filer)
| Form 20-F/A | |
09/28/2023 3:30 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023 3:30 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023 3:30 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/14/2023 3:01 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/13/2023 3:01 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2023 3:45 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2023 3:45 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2023 5:03 AM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023 4:20 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023 3:15 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2023 3:20 PM | CureVac (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |